Keystone Symposia: Fibrosis: Translation of Basic Research to Human Disease and Novel Therapeutics (Fibrosis)

Venue: Big Sky Resort

Location: Big Sky, Montana, United States

Event Date/Time: Mar 30, 2012 End Date/Time: Apr 04, 2012
Registration Date: Mar 30, 2012
Early Registration Date: Jan 30, 2012
Report as Spam


Fibrosis is a pathological process in which diseased tissue is replaced with excess extracellular matrix ultimately leading to organ scarring and failure, a final common pathway in many forms of chronic disease affecting multiple tissues. Currently, there are minimal and inadequate treatment options for fibrotic disease. The field of fibrosis is emerging and there is a strong need to understand the cellular, molecular and genetic basis of fibrosis in humans and to develop animal models that reproduce and dissect this pathological process. There is also a need to identify prognostic markers of disease susceptibility, biomarkers of disease progression and improved technologies to monitor the effectiveness of new therapies. The goal of the Keystone Symposia meeting on Fibrosis: Translation of Basic Research to Human Disease and Novel Therapeutics is to bring together researchers and clinicians in academia and industry to provide an integrated perspective of basic disease mechanisms, the more pragmatic challenges associated with executing clinical trials and approaches to improve clinical development of anti-fibrotic drugs.


Additional Information

Other deadlines: Abstract & scholarship - November 30, 2011 Late-breaking abstract - January 5, 2012